Gastrointestinal Cancer News

Despite achieving cure with direct-acting antivirals, patients with chronic hepatitis C virus-related decompensated cirrhosis remain at risk for progression of portal hypertension, further decompensation and hepatocellular carcinoma.

Declines in serum hepatitis B virus RNA at the first and second year of treatment with nucleos(t)ide analogues correlated with risk for hepatocellular carcinoma and may serve as independent predictors of cancer development.

The new blood test screening option for colorectal cancer is innovative and could improve screening uptake, but it also has some drawbacks, according to an expert.

In Healio video exclusive, Suneel Kamath, MD, reports a diet, especially one high in red and processed meats may be linked to an increased risk for early-onset colorectal cancer.

Analyses of people with early-onset colorectal cancer showed those who lived in rural areas had greater 5-year disease-related mortality risk than those who lived in nonrural areas, according to results of a retrospective study.

An AI-assisted endoscopy module increased adenoma detection, including sessile serrated lesions, during colonoscopy and is recommended in routine practice to reduce incidence of post-procedure colorectal cancer, according to researchers.

The addition of comprehensive metastasis-directed radiation therapy to chemotherapy improved outcomes for patients with oligometastatic pancreatic ductal adenocarcinoma, according to results of a randomized phase 2 basket trial.

The biomarker-based Esopredict determined that patients with Barrett’s esophagus who were stratified as higher risk were 6.4-times more likely to progress to high-grade dysplasia or esophageal adenocarcinoma within 5 years, research showed.

Revised quality indicators released by the ACG and ASGE highlight the importance of adenoma and sessile serrated lesion detection rates as well as adequate bowel preparation for improving the technical performance of colonoscopy.

Olanzapine significantly reduced nausea and vomiting compared with observation for patients with solid tumors undergoing moderately emetogenic chemotherapy, according to results of a randomized phase 3 trial.